Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells.

MLA

Mengeste, Abel M., et al. “Knockdown of Sarcolipin (SLN) Impairs Substrate Utilization in Human Skeletal Muscle Cells.” Molecular Biology Reports, vol. 49, no. 7, July 2022, pp. 6005–17. EBSCOhost, https://doi.org/10.1007/s11033-022-07387-0.

APA

Mengeste, A. M., Katare, P., Dalmao Fernandez, A., Lund, J., Bakke, H. G., Baker, D., Bartesaghi, S., Peng, X.-R., Rustan, A. C., Thoresen, G. H., & Kase, E. T. (2022). Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells. Molecular Biology Reports, 49(7), 6005–6017. https://doi.org/10.1007/s11033-022-07387-0

Chicago

Mengeste, Abel M, Parmeshwar Katare, Andrea Dalmao Fernandez, Jenny Lund, Hege G Bakke, David Baker, Stefano Bartesaghi, et al. 2022. “Knockdown of Sarcolipin (SLN) Impairs Substrate Utilization in Human Skeletal Muscle Cells.” Molecular Biology Reports 49 (7): 6005–17. doi:10.1007/s11033-022-07387-0.